Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial.

MLA

Giorgi Rossi, Paolo, et al. “Performance of HPV E6/E7 MRNA Assay as Primary Screening Test: Results from the NTCC2 Trial.” International Journal of Cancer, vol. 151, no. 7, Oct. 2022, pp. 1047–58. EBSCOhost, https://doi.org/10.1002/ijc.34120.

APA

Giorgi Rossi, P., Ronco, G., Mancuso, P., Carozzi, F., Allia, E., Bisanzi, S., Gillio-Tos, A., De Marco, L., Rizzolo, R., Gustinucci, D., Del Mistro, A., Frayle, H., Confortini, M., Iossa, A., Cesarini, E., Bulletti, S., Passamonti, B., Gori, S., Toniolo, L., … Benevolo, M. (2022). Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial. International Journal of Cancer, 151(7), 1047–1058. https://doi.org/10.1002/ijc.34120

Chicago

Giorgi Rossi, Paolo, Guglielmo Ronco, Pamela Mancuso, Francesca Carozzi, Elena Allia, Simonetta Bisanzi, Anna Gillio-Tos, et al. 2022. “Performance of HPV E6/E7 MRNA Assay as Primary Screening Test: Results from the NTCC2 Trial.” International Journal of Cancer 151 (7): 1047–58. doi:10.1002/ijc.34120.